Volunteering as an Intervention to Reduce Depression Among Adolescents

March 1, 2021 updated by: Wake Forest University Health Sciences

Volunteering as an Intervention to Reduce Depression Among Adolescents: Investigating Neurobiological Mechanisms

The purpose of the present study is to test in a preliminary manner an innovative strategy for treating depression among adolescents (alongside existing therapy) using community volunteerism.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The purpose of the present study is to test in a preliminary manner an innovative strategy for treating depression among adolescents (alongside existing therapy) using community volunteerism. In addition, this study will test a potential mechanism by which volunteering might decrease depressive symptoms: increasing psychosocial assets, specifically decreasing self-orientation and increasing an orientation toward others. This will be measured through self-report as well as using functional magnetic resonance imaging (fMRI). This study will be the first study to explore how neural response patterns are potentially altered by intense experiences with volunteerism among depressed adolescents.

Study Type

Interventional

Enrollment (Actual)

9

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27101
        • Trinity Center, Inc
      • Winston-Salem, North Carolina, United States, 27103
        • TriCare, PA
      • Winston-Salem, North Carolina, United States, 27106
        • Private Practice

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 14-20
  • new mild to moderate depression diagnosis (single episode)
  • new mild to moderate anxiety diagnosis
  • new adjustment disorder diagnosis
  • have been in treatment for < 8 months
  • right-handed

Exclusion Criteria:

  • history of recurrent depressive, anxiety or adjustment disorder episodes
  • have been in treatment > 8 months
  • left-handed
  • expressing suicidal ideation
  • claustrophobia
  • any contraindications for completing an MRI scan

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adolescent Participants
Participants will be assigned to participate in community service (from a menu of options) for 30 hours.
Participants will be assigned to a meaningful volunteer experience from a menu of local options (e.g., volunteering at an animal shelter or in a library) for 30 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant recruitment
Time Frame: 6 months
Number of participants screened (reported by clinical mental health providers)
6 months
Participant retention
Time Frame: 6 months
Number of participants retained in full study
6 months
Depressive symptoms (Beck Depression Inventory)
Time Frame: 6 months
Beck Depression Inventory to measure depressive symptoms. Each item is rated on a 4-point scale ranging from 0 to 3. The minimum total score is 0 and the maximum total score is 63. Higher scores denote worse outcome
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength of Connectivity in DMN (Default Mode Network)
Time Frame: 6 months
Default Mode Network Connectivity will be measured using fMRI at rest and while processing emotional pictures before and after volunteering intervention. The strength of connectivity within the DMN will be calculated by averaging attributes for each node in the DMN.
6 months
Hope scale (Abler et al., 2017)
Time Frame: 6 months
Hope scale (Abler et al., 2017) will be measured on a scale from 1 (strongly disagree) to 5 (strongly agree). Items will be averaged; higher scores denote better outcome (more hope).
6 months
Beck Hopelessness Inventory
Time Frame: 6 months
Beck Hopelessness Inventory will be used (scored from 1-20; higher score denotes worse outcome).
6 months
Self-efficacy
Time Frame: 6 months
NIH toolbox measure from 1 (never) to 5 (very often); scores will be averaged and high score indicates more self-efficacy.
6 months
Orientation Toward Others
Time Frame: 6 months
5 point scale from 1=strongly disagree to 5=strongly agree. Scores will be averaged; higher score denotes more orientation toward others.
6 months
Empathy
Time Frame: 6 months
IRI (Interpersonal Reactivity Index) subscale to measure empathy on a 5 point scale from 1- strongly disagree to 5 -strongly agree. Scores will be averaged; higher score denotes more empathy.
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experience in Volunteering
Time Frame: 6 months
Measured through the Inventory of Service Experience (Taylor & Pancer, 2007) on a scale from 1 (strongly disagree) to 5 (strongly agree). Scores will be averaged for subscales of the measure. Higher score denotes better outcomes (more positive experiences with volunteering).
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Parissa Ballard, PhD, Wake Forest University Health Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2019

Primary Completion (Actual)

August 1, 2020

Study Completion (Actual)

August 1, 2020

Study Registration Dates

First Submitted

January 22, 2019

First Submitted That Met QC Criteria

January 24, 2019

First Posted (Actual)

January 25, 2019

Study Record Updates

Last Update Posted (Actual)

March 2, 2021

Last Update Submitted That Met QC Criteria

March 1, 2021

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00053435

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe